{
  "abstract": "Monoclonal gammopathy of undetermined significance (MGUS) is a frequent hematological condition that occurs in later life. MGUS is associated with increased fragility fractures that mix individual osteoporotic risk factors, MGUS-related comorbidities, and direct MGUS bone impact such as senescence of plasma cells. This International Osteoporosis Foundation (IOF) position statement aims at evaluating the potential relationship between MGUS and fracture risk, as well as methods for evaluating bone involvement in MGUS. Finally, we propose the first bone clinical guidance for patients with MGUS to improve their bone health.\n\nBackground: Monoclonal gammopathy of undetermined significance is a prevalent hematological condition in adults, characterized by the presence of an abnormal monoclonal protein in the blood without concomitant symptoms or malignancy. MGUS is of considerable bone significance and contributes to fragility fractures in adults.\n\nMethods: In this review, data pertaining to bone fragility were collected, including epidemiological fracture data in patients with MGUS, bone mineral density (BMD), bone microarchitecture, bone turnover marker, and bone histomorphometry data.\n\nResults: Collectively, these findings suggest an elevated risk of fractures, especially in presence of osteoporotic risk factors or comorbidities, and a diminished BMD due to augmented bone resorption. Studies focusing on the treatment of this condition are limited.\n\nConclusion: Based on this analysis, we present the International Osteoporosis Foundation (IOF) position statement for bone evaluation and management of these patients. We recommend a risk-adapted treatment strategy. A proposal of bone clinical guidance dedicated to patients with MGUS is presented, suggesting bisphosphonates as the preferred treatment option.\n\nGraphical abstract:",
  "abstract_shown": true,
  "affiliations": [
    "Département de Rhumatologie Sud, Centre Expert Des Métastases Osseuses (CEMOS), Institut de Cancérologie Des Hospices Civils de Lyon, Hôpital Lyon Sud, 165 Ch du Grand Revoyet, Pierre-Bénite, 69495 France",
    "INSERM UMR1033 – LYOS, Université Claude Bernard Lyon 1, Université de Lyon, Lyon, 69100 France",
    "Centre de Recherche en Cancérologie de Lyon (CRCL), UMR INSERM 1052 CNRS 5286, Université Claude Bernard Lyon 1, Université de Lyon, Lyon, 69100 France",
    "CHU Angers, Service de Rhumatologie, Angers, 49933 France",
    "INSERM, Regenerative Medicine and Skeleton, Univ Angers, Nantes Université, Oniris, RMeS, UMR 1229, Angers, 49000 France",
    "Garvan Institute of Medical Research, Sydney, Australia",
    "Medical College of Wisconsin, Milwaukee, USA",
    "Frankfurt Center of Bone Health and Endocrinology, Frankfurt, Germany",
    "Philipps-University of Marburg, Marburg, Germany",
    "Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland",
    "Department of Medicine, CHU Brugmann, Université Libre de Bruxelles, Brussels, Belgium",
    "FIRMO Foundation, Florence, Italy",
    "Department of Medicine, Clinica Universidad de los Andes, Universidad de los Andes, Santiago de Chile, Chile",
    "Department of Medicine, School of Clinical Sciences, Monash University, Clayton, Melbourne, VIC Australia",
    "Rheumatology Office, Mohamed V University, Rabat, Morocco",
    "Dept. of Orthopedics, Medical University of Vienna, Vienna, Austria",
    "Department of Medicine, University of British Columbia, Vancouver, Canada",
    "Department of Gynaecology, Medical Faculty, Stellenbosch University, Western Cape, Stellenbosch, South Africa",
    "Osteoporosis Center, Hadassah Mount-Scopus University Hospital, Jerusalem, Israel"
  ],
  "article_type": "research article",
  "arxiv": null,
  "author_total": 15,
  "authors": [
    {
      "affs": [
        0,
        1,
        2
      ],
      "name": "Cyrille B. Confavreux",
      "orcid": "0000-0002-9318-6785"
    },
    {
      "affs": [
        3,
        4
      ],
      "name": "Beatrice Bouvard"
    },
    {
      "affs": [
        5,
        6
      ],
      "name": "Robert Blank"
    },
    {
      "affs": [
        7,
        8
      ],
      "name": "Peyman Hadji"
    },
    {
      "affs": [
        9
      ],
      "name": "Emmanuel Biver"
    },
    {
      "affs": [
        10
      ],
      "name": "Jean-Jacques Body"
    },
    {
      "affs": [
        11
      ],
      "name": "Maria Luisa Brandi"
    },
    {
      "affs": [
        12
      ],
      "name": "Claudia Campusano"
    },
    {
      "affs": [
        13
      ],
      "name": "Peter R. Ebeling"
    },
    {
      "affs": [
        14
      ],
      "name": "Abdellah El Maghraoui"
    },
    {
      "affs": [
        15
      ],
      "name": "Gerold Holzer"
    },
    {
      "affs": [
        16
      ],
      "name": "David Kendler"
    },
    {
      "affs": [
        17
      ],
      "name": "Tobie de Villiers"
    },
    {
      "affs": [
        9
      ],
      "name": "René Rizzoli"
    },
    {
      "affs": [
        18
      ],
      "name": "A. Joseph Foldes"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/75h2qg7pbdd9h.bib",
  "cited_by": 0,
  "doi": "10.1007/s00198-026-08178-0",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13751719/",
  "id": "75h2qg7pbdd9h",
  "issns": [
    "0937-941X",
    "1433-2965"
  ],
  "landing_url": "https://doi.org/10.1007/s00198-026-08178-0",
  "language": "en",
  "licence": "CC-BY-NC-4.0",
  "licence_label": "CC BY-NC 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Consensus Statement"
    ],
    [
      "openalex",
      "2732|Bone health and osteoporosis research"
    ]
  ],
  "openalex": "W7211972748",
  "pdf_url": "https://link.springer.com/content/pdf/10.1007/s00198-026-08178-0.pdf",
  "pmcid": "PMC13751719",
  "pmid": "42709184",
  "published": "2026-09-08",
  "publisher": null,
  "ris": "https://research.draconitic.com/paper/75h2qg7pbdd9h.ris",
  "sources": [
    {
      "first_seen": "2026-11-15T12:21:15Z",
      "native_id": "PMC13751719",
      "source": "pmc",
      "url": "https://doi.org/10.1007/s00198-026-08178-0"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2732|Bone health and osteoporosis research",
      "subfield": "surgery"
    }
  ],
  "title": "Clinical guidance on evaluation and management of bone fragility in patients with monoclonal gammopathy of undetermined significance (MGUS): an IOF position statement",
  "title_text": "Clinical guidance on evaluation and management of bone fragility in patients with monoclonal gammopathy of undetermined significance (MGUS): an IOF position statement",
  "type": "peer-reviewed",
  "updated_at": "2026-11-15T12:21:15Z",
  "url": "https://research.draconitic.com/paper/75h2qg7pbdd9h",
  "venue": "Osteoporosis International",
  "versions": []
}